Dermapharm Holding SE buy DirectorDealer
Start price
13.10.22
/
50%
€39.30
Target price
13.10.23
-
Performance (%)
-0.71%
End price
14.10.23
€39.02
Summary
This prediction ended on 14.10.23 with a price of €39.02. The BUY prediction by DirectorDealer for Dermapharm Holding SE closed nearly unchanged. DirectorDealer has a follow-up prediction for Dermapharm Holding SE where he still thinks Dermapharm Holding SE is a Buy. DirectorDealer has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermapharm Holding SE | -0.391% | -0.391% | -4.375% | -3.263% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by DirectorDealer for this prediction
In the thread Dermapharm Holding SE diskutieren
Director's Dealing / Insider Kauf von Themis Beteiligungs-Aktiengesellschaft (in enger Beziehung)
- Handelstag: 12.10.2022
- Volumen: 55825000 €
- Meldende_r: Themis Beteiligungs-Aktiengesellschaft
In the thread Trading Dermapharm Holding SE
Die von DirectorDealer gewählte maximale Laufzeit wurde überschritten